Paradromics
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4030 W Braker Ln Ste 250, Austin, Texas,...Phone Number
(512) 559-4120Website
www.paradromics.comRevenue
$9.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Paradromics
Paradromics is pioneering advanced brain-computer interface (BCI) technology aimed at restoring communication and independence for patients suffering from severe paralysis due to conditions like ALS, stroke, and spinal cord injuries. Their flagship product, Connexus, enables individuals who cannot speak to communicate through digital devices, while their upcoming product, Tempo, focuses on mental health brain-state monitoring. The company leverages high-resolution brain activity recording and AI algorithms to translate brain data into actionable health insights, addressing a wide range of neurological and mental health conditions. Paradromics is committed to developing scalable and long-lasting neurotechnology solutions to meet the needs of millions with unmet medical requirements.Explore more
Paradromics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Paradromics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Paradromics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Paradromics launches new products
Check out if Paradromics is spiking on competitors!
Click to see if Paradromics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Paradromics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Paradromics
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Paradromics recently announced quarterly report
Check if Paradromics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Paradromics
Find 3 more new buyers
Compare Similar Companies to Paradromics
Compare insights from companies similar to Paradromics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Paradromics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Paradromics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Paradromics.
Paradromics financials insights
Gather financial insights about Paradromics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$985K
2018
Angel/Seed
$7M
2020
Debt
$350K
2021
Angel/Seed
$20M
2023
Other Financing Round
$33M
Paradromics Tech Stack
A closer look at the technologies used by Paradromics
See more technologies
Most Recent Scoops
Person-Based
Language Technology, Medical Research, Artificial Intelligence, Language
Open Position
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Paradromics News & Media
Neuralink competitor Paradromics completes first human implant
The procedure took place at the University of Michigan with a patient who was already undergoing neurosurgery to treat epilepsy.Neuralink competitor Paradromics secures investment from Saudi Arabia's Neom
Paradromics has formed a strategic partnership with Saudi Arabia's NeomHealthy Returns: Brain implant Paradromics launches patient registry - CNBC
Brain implant company Paradromics is preparing for human trials, while President Biden's poor debate performance affected health-care stocks.Paradromics accepted to FDA regulatory accelerator program and announces new patient registry
AUSTIN, Texas, July 1, 2024 /PRNewswire/ -- Paradromics Inc., a leading developer of brain-computer interfaces (BCI), today announced its acceptance into the U.S. Food and Drug Administration's newest program for innovative devices, the Total Product Life Cycle Advisory Program. According...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Paradromics
Sign Up For FreeTo access detailed company insights
Paradromics is pioneering advanced brain-computer interface (BCI) technology aimed at restoring communication and independence for patients suffering from severe paralysis due to conditions like ALS, stroke, and spinal cord injuries. Their flagship product, Connexus, enables individuals who cannot speak to communicate through digital devices, while... Read More
